Topic
drug regulation
8 stories related to this topic, newest first.
Wiredworld6 days ago
Federal Officials Seek Schedule I Status for 7-OH Compound
Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary have called for the DEA to place 7-hydroxymitragynine under Schedule I restrictions. Kratom industry groups and some consumers oppose the move while others support limits on concentrated p…
thehindubusinessline.comscience4 days ago
BPC-157, a Peptide Discovered in 1989, Faces FDA Advisory Review on Compounding Use
Predrag Sikiric's research on the 15-amino-acid peptide began in 1983 and reached an FDA advisory committee scheduled for this summer. The compound is now part of a U.S. policy debate on access to unapproved peptides.
larrybrownsports.comworld36 days ago
FDA Names Mike Davis Acting Director of Drug Center
Dr. Tracy Beth Hoeg was removed from her role leading the FDA's Center for Drug Evaluation and Research on Friday and replaced by Dr. Mike Davis. The move is the latest in a series of high-level departures at the agency following the resignation of Commissioner Marty Makary and t…
thehindu.comscience39 days ago
Trump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reforms
The administration is moving quickly to find a successor after FDA Commissioner Marty Makary resigned on Tuesday. Officials want the next leader to rebuild trust with agency staff, emphasize food policy and continue drug-approval reforms. The search is expected to take several we…
Nbc Newspolitics40 days agoUpdated
Trump Removes FDA Commissioner Marty Makary
President Donald Trump announced Tuesday that Dr. Marty Makary has left his position as FDA commissioner following weeks of reported tensions with the White House. Kyle Diamantas, the agency's former top food official, will serve as acting commissioner.
nbcnews.compolitics43 days agoUpdated
Trump Removes FDA Commissioner Marty Makary
President Trump has approved a plan to dismiss FDA Commissioner Marty Makary after months of clashes over vaping approvals, vaccine policies, drug rejections and agency personnel turmoil. The move, first reported by the Wall Street Journal on May 8, 2026, would create another hig…
thehindu.comscience49 days ago
President Trump Orders Agencies to Accelerate Research on Psychedelic Drugs
President Trump directed federal agencies to expedite research into therapeutic uses of psychedelic substances like LSD, peyote and MDMA. This follows a recent Justice Department action to loosen medical marijuana restrictions. The move contrasts with decades of conservative oppo…
medpagetoday.comscience52 days ago
FDA Announces Panel Meeting on Allowing Compounding Pharmacies to Produce Certain Peptides
The U.S. Food and Drug Administration announced a panel meeting to discuss permitting compounding pharmacies to manufacture seven specific peptides. The meeting is scheduled for July 23 and 24. This follows the agency's 2023 decision to remove 19 peptides from an approved list fo…